Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial Post author:Sam Post published:February 5, 2018 Post category:BioPharma The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace You Might Also Like <b>Madhuri Hegde, PhD</b> Is Elected To The Board Of The <b>ACMG Foundation For Genetic And Genomic Medicine</b> August 3, 2017 AI Biotech Startup XtalPi Scores $15M From Google, Tencent and Sequoia January 23, 2018 The Hype Behind Massachusetts Biotech Corbus' Sole Pipeline Drug March 16, 2017
<b>Madhuri Hegde, PhD</b> Is Elected To The Board Of The <b>ACMG Foundation For Genetic And Genomic Medicine</b> August 3, 2017
